Please use this identifier to cite or link to this item: https://doi.org/10.1159/000076468
DC FieldValue
dc.titleFrequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma
dc.contributor.authorOshimo, Y.
dc.contributor.authorOue, N.
dc.contributor.authorMitani, Y.
dc.contributor.authorNakayama, H.
dc.contributor.authorKitadai, Y.
dc.contributor.authorYoshida, K.
dc.contributor.authorIto, Y.
dc.contributor.authorChayama, K.
dc.contributor.authorYasui, W.
dc.date.accessioned2016-12-13T05:33:31Z
dc.date.available2016-12-13T05:33:31Z
dc.date.issued2004
dc.identifier.citationOshimo, Y., Oue, N., Mitani, Y., Nakayama, H., Kitadai, Y., Yoshida, K., Ito, Y., Chayama, K., Yasui, W. (2004). Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 71 (3) : 137-143. ScholarBank@NUS Repository. https://doi.org/10.1159/000076468
dc.identifier.issn10152008
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/132532
dc.description.abstractThe RUNX3 gene is a member of the Runt domain family of transcription factors that are master regulators of gene expression in major developmental pathways. Recently, lack of RUNX3 function was found to be associated with genesis and progression of gastric carcinoma. We studied methylation of CpG islands in the RUNX3 gene by methylation-specific PCR in 80 gastric carcinoma specimens, 45 corresponding non-neoplastic mucosae, and 7 gastric carcinoma cell lines. We also measured levels of RUNX3 mRNA in 50 of the gastric carcinoma cases by quantitative RT-PCR and in the gastric carcinoma cell lines by RT-PCR. Hypermethylation of the RUNX3 promoter was found in 57 (71%) of 80 gastric carcinomas, and promoter hypermethylation of RUNX3 occurred more frequently in intestinal and diffuse-adherent type tumors than in diffuse-scattered type tumors (p = 0.046). Reduced RUNX3 expression was associated with promoter hypermethylation (p = 0. 036), however, there was no correlation between RUNX3 mRNA expression levels and T grade, N grade, tumor stage, or histological type. In corresponding non-neoplastic mucosae, hypermethylation of the RUNX3 promoter was found in 38 (84%) of 45 specimens. Among seven gastric carcinoma cell lines, three cell lines (MKN-28, MKN-74, TMK-1) with diminished expression of RUNX3 had promoter methylation and three cell lines (MKN-1, MKN-7, MKN-45) with RUNX3 expression showed no promoter methylation. Our results overall suggest that transcriptional inactivation of RUNX3 by promoter hypermethylation may participate in the stomach carcinogenesis. Copyright © 2004 S. Karger AG, Basel.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1159/000076468
dc.sourceScopus
dc.subjectDNA methylation
dc.subjectEpigenetic
dc.subjectGastric carcinoma
dc.subjectRUNX3
dc.subjectTransforming growth factor-beta
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1159/000076468
dc.description.sourcetitlePathobiology
dc.description.volume71
dc.description.issue3
dc.description.page137-143
dc.description.codenPATHE
dc.identifier.isiut000220501600004
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

64
checked on Nov 5, 2019

WEB OF SCIENCETM
Citations

58
checked on Nov 5, 2019

Page view(s)

25
checked on Nov 8, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.